Preimplantation genetic diagnosis (PGD) is the study of chromosomal or genetic alterations in the human embryo before transfer to the mother. It determines those embryos free of chromosomal abnormalities or genetic mutations. This review describes the 5-year experience including 711 cycles of an assisted reproduction center in Peru, performing PGD to embryos on day 3 of development. Preimplantation genetic diagnosis would be an effective tool to select embryos with higher implantation potential, which may lead to a healthy live birth. 

Preimplantation genetic diagnosis (PGD) is the study of chromosomal or genetic alterations in the human embryo before transfer to the mother. It determines those embryos free of chromosomal abnormalities or genetic mutations. This review describes the 5-year experience including 711 cycles of an assisted reproduction center in Peru, performing PGD to embryos on day 3 of development. Preimplantation genetic diagnosis would be an effective tool to select embryos with higher implantation potential, which may lead to a healthy live birth. 

The seminal parameters analyzed in semen (concentration, motility, morphology) do not clearly discriminate patients with fertility problems. For this reason it is necessary to search for new markers that willallow us to correlate the cause of male factor infertility with the likelihood of achieving a pregnancy reaching term. In recent years much research has focused on the molecular area, assessing DNA fragmentation and sperm chromosome aneuploidy, which has led to the term ‘genomic male factor infertility’. At present methodologies allow selection of sperm with less pathology for use in assisted reproduction procedures (ART) including morphological selection of spermatozoa by high magnification (IMSI), columns of annexin-V, and sperm selection by hyaluronic acid binding. This review will detail the usefulness of testing both DNA fragmentation and FISH in sperm as sperm selection tec...

The seminal parameters analyzed in semen (concentration, motility, morphology) do not clearly discriminate patients with fertility problems. For this reason it is necessary to search for new markers that willallow us to correlate the cause of male factor infertility with the likelihood of achieving a pregnancy reaching term. In recent years much research has focused on the molecular area, assessing DNA fragmentation and sperm chromosome aneuploidy, which has led to the term ‘genomic male factor infertility’. At present methodologies allow selection of sperm with less pathology for use in assisted reproduction procedures (ART) including morphological selection of spermatozoa by high magnification (IMSI), columns of annexin-V, and sperm selection by hyaluronic acid binding. This review will detail the usefulness of testing both DNA fragmentation and FISH in sperm as sperm selection tec...

We report pregnancy in a 42 year-old patient who received donated cryopreserved oocytes. Eight of 10 frozen-thawed oocytes survived and ICSI was performed two hours after culture at 37ºC. After 3 days in culture 3 good quality embryos were transferred obtaining a pregnancy consisting in two gestational sacs, currently live newborns.

We report pregnancy in a 42 year-old patient who received donated cryopreserved oocytes. Eight of 10 frozen-thawed oocytes survived and ICSI was performed two hours after culture at 37ºC. After 3 days in culture 3 good quality embryos were transferred obtaining a pregnancy consisting in two gestational sacs, currently live newborns.

Known causes of unsuccessful pregnancy in couples undergoing assisted reproduction treatment include embryo aneuploidies. Preimplantation genetic diagnosis (PGD) is a technique used in assisted reproduction in order to detect these abnormalities, select embryos chromosomally normal and subsequently transfer to the patients’ uterus. Embryos with single aneuploidies may have the ability to survive and achieve unnoticed implantation. Objectives: To determine incidence of single aneuploidies in good quality embryos in third day of development to blastocyst. Design: Statistical and experimental study. Setting: Reprogenetics Latin-America and Assisted Reproduction Center - Concebir. Biologic material: Samples of embryo biopsies. Methods: Comparative analysis of results from evaluation of each sample obtained by embryo biopsy on the third and fifth days of embryonic development, performing PG...

The GnRH antagonists (GnRHant) protocol has allowed the use of GnRH agonist (GnRHa) as inductor of ovulatory discharge (OD) replacing human chorionic gonadotropin (hCG). An important advantage of GnRHa use in OD is that it significantly decreases the risk of ovarian hyperstimulation syndrome (OHSS) due to its luteolytic effect, important in cases of oocyte donors. Objectives: To compare proportion of oocytes obtained, oocyte/embryo  quality, reproductive result and OHSS incidence in consecutive oocyte donation cycles when OD was done with hCG or GnRHa. Cycles with preimplantation genetic diagnosis were compared. Design: Cohort retrospective study. Setting: Grupo PRANOR, Clinica Concebir, Lima, Peru. Participants: Oocyte donors and receptors. Interventions: A GnRHant protocol was used in 43 oocyte donors for 203 consecutive stimulation cycles and OD with hCG (n=127) or GnRHa (n=76) based...

The GnRH antagonists (GnRHant) protocol has allowed the use of GnRH agonist (GnRHa) as inductor of ovulatory discharge (OD) replacing human chorionic gonadotropin (hCG). An important advantage of GnRHa use in OD is that it significantly decreases the risk of ovarian hyperstimulation syndrome (OHSS) due to its luteolytic effect, important in cases of oocyte donors. Objectives: To compare proportion of oocytes obtained, oocyte/embryo  quality, reproductive result and OHSS incidence in consecutive oocyte donation cycles when OD was done with hCG or GnRHa. Cycles with preimplantation genetic diagnosis were compared. Design: Cohort retrospective study. Setting: Grupo PRANOR, Clinica Concebir, Lima, Peru. Participants: Oocyte donors and receptors. Interventions: A GnRHant protocol was used in 43 oocyte donors for 203 consecutive stimulation cycles and OD with hCG (n=127) or GnRHa (n=76) based...

Background: Preimplantation genetic screening (PGS) using comparative genomics hybridization  (aCGH) and single nucleotide polymorphism (SNP) technology has become a useful tool in assisted reproduction by improving clinical outcomes. Both techniques identify aneuploidies and chromosomal rearrangement. However, SNPs with Parental Support (Natera Inc.) give extra information of the aneuploidy origin either from the sperm or the oocyte. Objectives: To determine single aneuplodies rate in human embryos obtained by assisted reproduction using single nucleotide polymorphism microarray. Design: Retrospective study. Setting: Grupo PRANOR, Sede Monterrico, and Genomics Peru, Lima, Peru. Biologic material: Human embryos. Interventions: From 2011 to 2013, 105 patients underwent IVF/ICSI with SNPs and Parental Support. In total, 429 embryos were analyzed and records were reviewed. Main outcome mea...

Background: Preimplantation genetic screening (PGS) using comparative genomics hybridization  (aCGH) and single nucleotide polymorphism (SNP) technology has become a useful tool in assisted reproduction by improving clinical outcomes. Both techniques identify aneuploidies and chromosomal rearrangement. However, SNPs with Parental Support (Natera Inc.) give extra information of the aneuploidy origin either from the sperm or the oocyte. Objectives: To determine single aneuplodies rate in human embryos obtained by assisted reproduction using single nucleotide polymorphism microarray. Design: Retrospective study. Setting: Grupo PRANOR, Sede Monterrico, and Genomics Peru, Lima, Peru. Biologic material: Human embryos. Interventions: From 2011 to 2013, 105 patients underwent IVF/ICSI with SNPs and Parental Support. In total, 429 embryos were analyzed and records were reviewed. Main outcome mea...